PortfoliosLab logoPortfoliosLab logo
GN0M.DE vs. WH2E.DE
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

GN0M.DE vs. WH2E.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and Invesco S&P World Health Care ESG UCITS ETF Acc (WH2E.DE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

GN0M.DE vs. WH2E.DE - Yearly Performance Comparison


2026 (YTD)202520242023
GN0M.DE
Global X Genomics & Biotechnology UCITS ETF
-1.91%5.67%-12.40%-8.07%
WH2E.DE
Invesco S&P World Health Care ESG UCITS ETF Acc
-3.21%2.78%7.94%1.68%

Returns By Period

In the year-to-date period, GN0M.DE achieves a -1.91% return, which is significantly higher than WH2E.DE's -3.21% return.


GN0M.DE

1D
-0.80%
1M
-2.32%
YTD
-1.91%
6M
13.11%
1Y
31.83%
3Y*
-4.64%
5Y*
10Y*

WH2E.DE

1D
-0.07%
1M
-4.35%
YTD
-3.21%
6M
4.08%
1Y
-0.98%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


GN0M.DE vs. WH2E.DE - Expense Ratio Comparison

GN0M.DE has a 0.50% expense ratio, which is higher than WH2E.DE's 0.18% expense ratio.


Return for Risk

GN0M.DE vs. WH2E.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GN0M.DE
GN0M.DE Risk / Return Rank: 5757
Overall Rank
GN0M.DE Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
GN0M.DE Sortino Ratio Rank: 5656
Sortino Ratio Rank
GN0M.DE Omega Ratio Rank: 4747
Omega Ratio Rank
GN0M.DE Calmar Ratio Rank: 7171
Calmar Ratio Rank
GN0M.DE Martin Ratio Rank: 5555
Martin Ratio Rank

WH2E.DE
WH2E.DE Risk / Return Rank: 1111
Overall Rank
WH2E.DE Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
WH2E.DE Sortino Ratio Rank: 1010
Sortino Ratio Rank
WH2E.DE Omega Ratio Rank: 1010
Omega Ratio Rank
WH2E.DE Calmar Ratio Rank: 1212
Calmar Ratio Rank
WH2E.DE Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GN0M.DE vs. WH2E.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and Invesco S&P World Health Care ESG UCITS ETF Acc (WH2E.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GN0M.DEWH2E.DEDifference

Sharpe ratio

Return per unit of total volatility

1.03

-0.06

+1.09

Sortino ratio

Return per unit of downside risk

1.55

0.04

+1.51

Omega ratio

Gain probability vs. loss probability

1.19

1.01

+0.19

Calmar ratio

Return relative to maximum drawdown

2.34

0.09

+2.25

Martin ratio

Return relative to average drawdown

6.84

0.18

+6.67

GN0M.DE vs. WH2E.DE - Sharpe Ratio Comparison

The current GN0M.DE Sharpe Ratio is 1.03, which is higher than the WH2E.DE Sharpe Ratio of -0.06. The chart below compares the historical Sharpe Ratios of GN0M.DE and WH2E.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


GN0M.DEWH2E.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.03

-0.06

+1.09

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.44

0.22

-0.66

Correlation

The correlation between GN0M.DE and WH2E.DE is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

GN0M.DE vs. WH2E.DE - Dividend Comparison

Neither GN0M.DE nor WH2E.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

GN0M.DE vs. WH2E.DE - Drawdown Comparison

The maximum GN0M.DE drawdown since its inception was -67.19%, which is greater than WH2E.DE's maximum drawdown of -22.19%. Use the drawdown chart below to compare losses from any high point for GN0M.DE and WH2E.DE.


Loading graphics...

Drawdown Indicators


GN0M.DEWH2E.DEDifference

Max Drawdown

Largest peak-to-trough decline

-67.19%

-22.19%

-45.00%

Max Drawdown (1Y)

Largest decline over 1 year

-16.68%

-12.44%

-4.24%

Current Drawdown

Current decline from peak

-48.81%

-10.42%

-38.39%

Average Drawdown

Average peak-to-trough decline

-42.98%

-6.60%

-36.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.70%

4.65%

+1.05%

Volatility

GN0M.DE vs. WH2E.DE - Volatility Comparison

Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a higher volatility of 9.00% compared to Invesco S&P World Health Care ESG UCITS ETF Acc (WH2E.DE) at 4.14%. This indicates that GN0M.DE's price experiences larger fluctuations and is considered to be riskier than WH2E.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


GN0M.DEWH2E.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.00%

4.14%

+4.86%

Volatility (6M)

Calculated over the trailing 6-month period

21.02%

9.11%

+11.91%

Volatility (1Y)

Calculated over the trailing 1-year period

30.79%

17.43%

+13.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.56%

13.68%

+17.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.56%

13.68%

+17.88%